Pan-coronavirus fusion inhibitors as the hope for today and tomorrow

作     者：Xinling Wang Shuai Xia Yun Zhu Lu Lu Shibo Jiang Xinling Wang;Shuai Xia;Yun Zhu;Lu Lu;Shibo Jiang

作者机构：Key Laboratory of Medical Molecular Virology(MOE/NHC/CAMS)School of Basic Medical SciencesFudan UniversityShanghai200032China National Laboratory of BiomacromoleculesInstitute of BiophysicsChinese Academy of SciencesBeijing100101China 

出 版 物：《Protein & Cell》 (蛋白质与细胞（英文版）)

年 卷 期：2021年第12卷第2期

页      面：84-88页

核心收录：

学科分类：0710[理学-生物学] 1001[医学-基础医学(可授医学、理学学位)] 100103[医学-病原生物学] 10[医学] 

基　　金：This work was supported by the National Megaprojects of China for Major Infectious Diseases(2018ZX10301403 to L.L.) Program of Shanghai Academic/Technology Research Leader(20XD1420300 to L.L.) the National Natural Science Foundation of China(81822045 to L.L.,81630090 to S.J.). 

主　　题：al. Graham respiratory 

摘      要：The last two decades of the 21st century have seen emerging zoonotic coronavirus(CoV)diseases,including severe acute respiratory syndrome(SARS)(Holmes 2003),Middle East respiratory syndrome(MERS)(Graham et al.,2013)and coronavirus disease 2019(COVID-19)(Jiang et al.,2020).